JAZZ
Jazz Pharmaceuticals plcCompany with tickers: JAZZ
Market Cap
$14.14B
Shares Outstanding
62,742,820
CIK
1232524
CUSIP
G50871105
13F Activity (30d)
30 filings
7 filers
Website
Visit website
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$500,000,000
as of 2024-07-31
Remaining Authorization
$225,000,000
as of 2026-03-31
Program Utilization
55.0%
$275,000,000 used of $500,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $125,023,000 | 10-K, filed 2026-02-24 | ||
| 2024-12-31 | $311,429,000 | 10-K, filed 2026-02-24 | ||
| 2023-12-31 | $269,761,000 | 10-K, filed 2026-02-24 | ||
| 2022-12-31 | $54,000 | 10-K, filed 2025-02-26 | ||
| 2021-12-31 | $0 | 10-K, filed 2024-02-28 | ||
| 2020-12-31 | $146,537,000 | 10-K, filed 2023-03-01 | ||
| 2019-12-31 | $301,450,000 | 10-K, filed 2022-03-01 | ||
| 2018-12-31 | $523,672,000 | 10-K, filed 2021-02-23 | ||
| 2017-12-31 | $98,799,000 | 10-K, filed 2020-02-25 | ||
| 2016-12-31 | $278,296,000 | 10-K, filed 2019-02-26 | ||
| 2015-12-31 | $61,553,000 | 10-K, filed 2018-02-27 | ||
| 2014-12-31 | $42,215,000 | 10-K, filed 2017-02-28 | ||
| 2013-12-31 | $136,484,000 | 10-K, filed 2016-02-23 | ||